[1]
Ahmud, M.W., Mustafa, M. and Asim, W. 2025. A rare disease gets a breakthrough: Ctexli approved for cerebrotendinous xanthomatosis. International Journal of Basic & Clinical Pharmacology. 14, 4 (Jun. 2025), 649–650. DOI:https://doi.org/10.18203/2319-2003.ijbcp20251852.